Cargando…
Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high)
Integrin β4 (ITGB4) is a member of the integrin family, which plays a crucial role in mediating cell adhesion to the extracellular matrix. Recent studies have demonstrated that ITGB4 is involved in tumorigenesis and metastasis during the development of cancer. However, the role of ITGB4 in oral squa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296360/ https://www.ncbi.nlm.nih.gov/pubmed/37371594 http://dx.doi.org/10.3390/biom13061014 |
_version_ | 1785063639788552192 |
---|---|
author | Ma, Si-Rui Liu, Jian-Feng Jia, Rong Deng, Wei-Wei Jia, Jun |
author_facet | Ma, Si-Rui Liu, Jian-Feng Jia, Rong Deng, Wei-Wei Jia, Jun |
author_sort | Ma, Si-Rui |
collection | PubMed |
description | Integrin β4 (ITGB4) is a member of the integrin family, which plays a crucial role in mediating cell adhesion to the extracellular matrix. Recent studies have demonstrated that ITGB4 is involved in tumorigenesis and metastasis during the development of cancer. However, the role of ITGB4 in oral squamous cell carcinoma (OSCC) remains unclear. A Multiplex immunohistochemistry (OPAL™, mIHC) assay was employed to stain ITGB4, ALDH1, PD-L1, cytokeratin (CK), CD8 and PD-1 in a human OSCC tissue microarray, containing 26 normal oral epithelium samples, 21 oral epithelium dysplasia samples and 76 OSCC samples. The expression pattern and clinicopathological characteristics of ITGB4 were analyzed and compared with those of PD-1, PD-L1, ALDH1 and CD8. The correlation between subgroups of tumor cells, including ITGB4(+)PD-L1(+) and ITGB4(+)ALDH1(+), and subgroups of T cells, including CD8(+) and CD8(+)PD-1(+), was evaluated using two-tailed Pearson’s statistics. A Kaplan–Meier curve was built, and a log-rank test was performed to analyze the survival rate of different subgroups. The mIHC staining results show that ITGB4 was mostly expressed in the tumor cells, with a significant increase in the OSCC specimens compared with normal oral epithelium and oral epithelium dysplasia. The paired analysis, conducted between the OSCC tumor tissue and normal paracancer mucosa, confirmed the results. The study further revealed that ITGB4(+)PD-L1(+) cancer cells, but not ITGB4(+)ALDH1(+) cancer cells, were significantly associated with the infiltration of CD8(+) T cells (positivity p = 0.005, positive number p = 0.03). Additionally, ITGB4(+)PD-L1(+) tumor cells were positively correlated with CD8(+)PD-1(+) T cells (positivity p = 0.02, positive number p = 0.03). Most intriguingly, the subgroup of ITGB4/PD-L1(high) with CD8/PD-1(high) displayed the best prognosis compared with the other considered subgroups. The results show that the expression of ITGB4 was increased in OSCC compared with normal oral mucosa. Furthermore, a specific subgroup with high levels of expression of ITGB4/PD-L1 and CD8/PD-1 was found to have a relatively better prognosis compared with the other subgroups. Ultimately, this study sheds light on the potential role of ITGB4 in OSCC and provides a basis for further investigation. |
format | Online Article Text |
id | pubmed-10296360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102963602023-06-28 Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high) Ma, Si-Rui Liu, Jian-Feng Jia, Rong Deng, Wei-Wei Jia, Jun Biomolecules Article Integrin β4 (ITGB4) is a member of the integrin family, which plays a crucial role in mediating cell adhesion to the extracellular matrix. Recent studies have demonstrated that ITGB4 is involved in tumorigenesis and metastasis during the development of cancer. However, the role of ITGB4 in oral squamous cell carcinoma (OSCC) remains unclear. A Multiplex immunohistochemistry (OPAL™, mIHC) assay was employed to stain ITGB4, ALDH1, PD-L1, cytokeratin (CK), CD8 and PD-1 in a human OSCC tissue microarray, containing 26 normal oral epithelium samples, 21 oral epithelium dysplasia samples and 76 OSCC samples. The expression pattern and clinicopathological characteristics of ITGB4 were analyzed and compared with those of PD-1, PD-L1, ALDH1 and CD8. The correlation between subgroups of tumor cells, including ITGB4(+)PD-L1(+) and ITGB4(+)ALDH1(+), and subgroups of T cells, including CD8(+) and CD8(+)PD-1(+), was evaluated using two-tailed Pearson’s statistics. A Kaplan–Meier curve was built, and a log-rank test was performed to analyze the survival rate of different subgroups. The mIHC staining results show that ITGB4 was mostly expressed in the tumor cells, with a significant increase in the OSCC specimens compared with normal oral epithelium and oral epithelium dysplasia. The paired analysis, conducted between the OSCC tumor tissue and normal paracancer mucosa, confirmed the results. The study further revealed that ITGB4(+)PD-L1(+) cancer cells, but not ITGB4(+)ALDH1(+) cancer cells, were significantly associated with the infiltration of CD8(+) T cells (positivity p = 0.005, positive number p = 0.03). Additionally, ITGB4(+)PD-L1(+) tumor cells were positively correlated with CD8(+)PD-1(+) T cells (positivity p = 0.02, positive number p = 0.03). Most intriguingly, the subgroup of ITGB4/PD-L1(high) with CD8/PD-1(high) displayed the best prognosis compared with the other considered subgroups. The results show that the expression of ITGB4 was increased in OSCC compared with normal oral mucosa. Furthermore, a specific subgroup with high levels of expression of ITGB4/PD-L1 and CD8/PD-1 was found to have a relatively better prognosis compared with the other subgroups. Ultimately, this study sheds light on the potential role of ITGB4 in OSCC and provides a basis for further investigation. MDPI 2023-06-19 /pmc/articles/PMC10296360/ /pubmed/37371594 http://dx.doi.org/10.3390/biom13061014 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ma, Si-Rui Liu, Jian-Feng Jia, Rong Deng, Wei-Wei Jia, Jun Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high) |
title | Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high) |
title_full | Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high) |
title_fullStr | Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high) |
title_full_unstemmed | Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high) |
title_short | Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high) |
title_sort | identification of a favorable prognostic subgroup in oral squamous cell carcinoma: characterization of itgb4/pd-l1(high) with cd8/pd-1(high) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296360/ https://www.ncbi.nlm.nih.gov/pubmed/37371594 http://dx.doi.org/10.3390/biom13061014 |
work_keys_str_mv | AT masirui identificationofafavorableprognosticsubgroupinoralsquamouscellcarcinomacharacterizationofitgb4pdl1highwithcd8pd1high AT liujianfeng identificationofafavorableprognosticsubgroupinoralsquamouscellcarcinomacharacterizationofitgb4pdl1highwithcd8pd1high AT jiarong identificationofafavorableprognosticsubgroupinoralsquamouscellcarcinomacharacterizationofitgb4pdl1highwithcd8pd1high AT dengweiwei identificationofafavorableprognosticsubgroupinoralsquamouscellcarcinomacharacterizationofitgb4pdl1highwithcd8pd1high AT jiajun identificationofafavorableprognosticsubgroupinoralsquamouscellcarcinomacharacterizationofitgb4pdl1highwithcd8pd1high |